Digene Uses Pharma DTC/Physician-Sales Model To Drive HPV Test Adoption
This article was originally published in The Gray Sheet
Executive Summary
Digene is channeling its 65-rep clinician sales force and direct-to-consumer advertising to make DNAwithPap tests the standard of care for cervical cancer screening
You may also be interested in...
Execs Should Monitor Advocacy Group Concerns, Media Coverage – Diermeier
Medical device executives should stay abreast of advocacy group concerns and media portrayal in order to effectively manage the image of their products, according to Daniel Diermeier, PhD, Northwestern University
Execs Should Monitor Advocacy Group Concerns, Media Coverage – Diermeier
Medical device executives should stay abreast of advocacy group concerns and media portrayal in order to effectively manage the image of their products, according to Daniel Diermeier, PhD, Northwestern University
Digene DTC Campaign Pushes HPV Test Adoption, Consumer Education
Digene will spend up to $6 mil. on a direct-to-consumer advertising campaign aimed at bolstering sales of its DNAwithPap human papillomavirus test, the company said